Stem cell gene therapy could be key to treating Duchenne muscular dystrophy

(University of California - Los Angeles Health Sciences) Scientists at UCLA have developed a new approach that could eventually be used to treat Duchenne muscular dystrophy. The stem cell gene therapy could be applicable for 60 percent of people with Duchenne, which affects approximately 1 in 5,000 boys in the US and is the most common fatal childhood genetic disease.